NIAID supports a comprehensive AIDS therapeutics research program with the goal of developing new and better approaches to treat and control HIV infection and associated co-infections and complications.
Bulletin: HVTN 505 HIV Vaccine Study Begins Enrolling Volunteers—Aug. 24, 2009
Q&A: The HVTN 505 HIV Vaccine Regimen Study—Aug. 24, 2009
Statement: NIAID Modifies Trial Involving Antiretroviral Therapy in HIV-infected InfantsJuly 2, 2007